As of Jul 21
| 0.00 / 0.00%|
The 1 analysts offering 12-month price forecasts for Acasti Pharma Inc have a median target of 7.41, with a high estimate of 7.41 and a low estimate of 7.41. The median estimate represents a +478.77% increase from the last price of 1.28.
The current consensus among 1 polled investment analysts is to Buy stock in Acasti Pharma Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.